AB0834 Better improvement of asdas were achieved in 841 as patients among 6 months of anti-tnf users compared to non-anti-tnf users: results from a real world prospective cohort managed by smart phone system
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3186
Abstract: Background Ankylosing spondylitis (AS) is a chronic and progressive condition of the spine, which is the most common form of spondyloarthritis (SpA). Although anti-TNF agents are the most effective therapy for AS or SpA, it… read more here.
Keywords: non anti; tnf users; months anti; disease ... See more keywords